James Lousararian
InvestorManaging Director at Bioventures Investors
About
James (Jim) Lousararian, JD, joined BioVentures Investors as Managing Director in 2017 with over 20 years of life sciences and healthcare entrepreneurship. A serial entrepreneur, he co-founded and/or led several startups including Verax Biomedical (where he remains CEO), AngioLink, Spirus, ArthroSurface, and Nursery Products, and previously held executive roles at Thermo Electron/Thermo ReTec. He holds a BBA from UMass Amherst and a JD from the University of Chicago.
Contact· self-published, not guessed
Invests in
BiotechHealthtechMedical Devices
Deals · 1
3DBiopsyBoard seat
via Bioventures Investors · filed Jun 2022 · $500K raise
Attribution from SEC filings, press coverage, and firm rosters.
Other disclosed investments
Board seats
CareSignalTriopsy MedicalUnified Information DevicesVerax Biomedical
Sources: SEC Form D filings · the firm's website.
Colleagues at Bioventures Investors
Frequently asked questions
- Who is James Lousararian?
- James (Jim) Lousararian, JD, joined BioVentures Investors as Managing Director in 2017 with over 20 years of life sciences and healthcare entrepreneurship. A serial entrepreneur, he co-founded and/or led several startups including Verax Biomedical (where he remains CEO), AngioLink, Spirus, ArthroSurface, and Nursery Products, and previously held executive roles at Thermo Electron/Thermo ReTec. He holds a BBA from UMass Amherst and a JD from the University of Chicago.
- Where does James Lousararian work?
- James Lousararian is Managing Director at Bioventures Investors.
- What does James Lousararian invest in?
- James Lousararian invests in Biotech, Healthtech, Medical Devices.
- What boards does James Lousararian sit on?
- James Lousararian holds tracked board seats at 3DBiopsy, CareSignal, Triopsy Medical, Unified Information Devices, Verax Biomedical.